期刊文献+

帕金森病患者基底节区的磁共振氨基质子转移成像研究 被引量:7

Amide proton transfer MR imaging at 3.0 T of the basal ganglia in Parkinson's disease
原文传递
导出
摘要 目的 探讨磁共振氨基质子转移成像(APT)技术对于发现帕金森病患者基底节异常改变的可行性.方法 收集27例帕金森病患者和23名年龄及性别相匹配的健康对照者进行头颅APT成像和常规磁共振检查.测量双侧苍白球、壳核和尾状核的酰胺质子不对称磁化转移率(MTRasym),分别采用独立样本t检验和配对样本t检验比较帕金森病患者与健康对照者、帕金森病患者起病侧和对侧各脑结构MTRasym (3.5 ppm)的差异.使用单因素方差分析比较健康对照者和不同严重程度帕金森病患者间各脑结构MTRasym(3.5 ppm)的差异.结果 帕金森病患者苍白球、壳核和尾状核的MTRasym (3.5 ppm)均高于健康对照者[分别为(0.89±0.12)%与(0.57 ±0.16)%,(1.05±0.11)%与(0.82±0.15)%,(1.15±0.13)%与(0.78 ± 0.19)%;t=3.311、2.562和3.277,均P<0.05].健康对照组、轻度和中重度帕金森病组基底节各脑结构MTRasym(3.5 ppm)的差异具有统计学意义,且轻度帕金森病患者苍白球、壳核和尾状核的MTRasym(3.5 ppm)明显高于健康对照者.帕金森病患者基底节各脑结构起病侧的MTRasym(3.5 ppm)虽均略低于对侧,但差异均无统计学意义.结论 APT成像技术可以敏感地显示早期帕金森病患者和健康对照者基底节各脑结构MTRasym(3.5 ppm)的差异,是一种评价帕金森病患者脑代谢异常的有效工具. Objective To explore the feasibility of amide proton transfer (APT) MR imaging for the detection of basal ganglia abnormalities in patients with Parkinson' s disease (PD).Methods Twentyseven patients with PD and twenty-three age-matched normal control subjects underwent cerebral APT and structural MR imaging.The magnetic resonance ratio asymmetry (MTRasym) values at 3.5 ppm of bilateral globus pallidus,putamen and caudate were measured on APT images.MTRasym (3.5 ppm) values of cerebral structures between PD patients and control subjects were compared with independent-samples t test.Paired-samples t test was used to compare the difference of MTRasym (3.5 ppm) between the side of onset and contralateral side in patients with PD.The difference of MTRasym (3.5 ppm) among normal controls,early-stage PD,and advanced-stage PD patients was assessed with one-way analysis of variance.Results Compared to normal controls,MTRasym(3.5 ppm) values of globus pallidus,putamen and caudate were significantly increased in PD patients ((0.89 ±0.12)% vs (0.57 ±0.16)%,(1.05 ± 0.11)% vs (0.82 ± 0.15)%,(1.15 ±0.13)% vs (0.78 ±0.19)%; t =3.311,2.562,3.277 respectively,all P values < 0.05).Significant differences in MTRasym (3.5 ppm) values of these cerebral structures were observed among normal controls,early-stage PD and advanced-stage PD patients.And MTRasym (3.5 ppm) values in globus pallidus,putamen and caudate were significantly higher in early-stage PD patients than normal controls.In PD patients,even not statistically significant,MTRasym (3.5 ppm)values of sides of onset were slightly lower than contralateral sides.Conclusions APT MR imaging can sensitively identify the difference of MTRasym (3.5 ppm) in the basal ganglia between PD patients and normal controls.APT might be a useful tool to evaluate abnormal metabolite in basal ganglia of PD patients.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2015年第1期40-43,共4页 Chinese Journal of Neurology
基金 “十二五”国家科技支撑计划项目(2012BAI10B04,2012BAI10B03)
关键词 帕金森病 基底神经节 磁共振成像 氨基质子转移 Parkinson disease Basal ganglia Magnetic resonance imaging Amide proton transfer
  • 相关文献

参考文献14

  • 1颜莉蓉.帕金森病脑功能网络的影像学研究进展[J].中华神经科杂志,2011,44(12):857-859. 被引量:4
  • 2Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson's disease[J]. Lancet Neurol, 2006, 5 (1 ) : 75-86.
  • 3黄新明,孙斌,薛蕴菁,段青.磁敏感加权成像检测帕金森病患者脑铁沉积[J].中华医学杂志,2010,90(43):3054-3058. 被引量:20
  • 4ZhouJ ,Tryggestad E, Wen Z, et aI. Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides[J] . Nature Med, 2011 , 17 ( 1 ) : 130-134.
  • 5韦茂彬,沈智威,肖刚,邱庆春,陈耀文,吴仁华.基于pH值敏感的磁化传递技术在1.5T磁共振成像上的研究[J].磁共振成像,2012,3(1):40-43. 被引量:10
  • 6ZhouJ, PayenJ , Wilson DA, et aI. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI[J]. Nat Med, 2003, 9(8): 1085-1090.
  • 7Jokivarsi KT, Gruhn HI, Grahn OH, et aI. Proton transfer ratio, lactate, and intracellular pH in acute cerebral ischemia[J]. Magn Reson Med, 2007, 57 (4) : 64Hi53.
  • 8Dula AN ,Arlinghaus LR, Dortch RD, et al. Amide proton transfer imaging of the breast at 3 T: establishing reproducibility and possible feasibility assessing chemotherapy response[J] . Magn Reson Med, 2013, 70(1) : 216-224.
  • 9张格,王显龙,路世龙,黄凡衡,温志波.磁共振氨基质子转移成像在神经上皮组织肿瘤分级诊断中的应用[J].中华神经外科杂志,2013,29(10):1005-1008. 被引量:6
  • 10Zhao X, Wen Z, Huang F, et aI. Saturation power dependence of amide proton transfer image contrasts in human brain tumors and strokes at 3 T[J]. Magn Reson Med, 2011,66(4): 1033-1O4l.

二级参考文献99

  • 1王新德.帕金森病及帕金森综合征的诊断标准和鉴别诊断[J].中华神经精神科杂志,1985,18(4):256-256.
  • 2Hughes AJ,Daniel SE,Kilford L,et al.Accuracy of clinical diagnosis of idiopathic Parkinson's disease:a clinico-pathological study of 100 cases.J Neurol Neurosurg Psychiat.
  • 3Haddar D,Haacke EM,Sehgal V,et al.Susceptibility weighted imaging.Theory and applications.J Radiol,2004,85:1901-1908.
  • 4Kirsch W,McAuley G,Holshouser B,et al.Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia.J Alzheimers Dis,2009,17:599-609.
  • 5Manova ES,Habib CA,Boikov AS,et al.Characterizing the mesencephalon using susceptibility-weighted imaging.AJNR Am J Neuroradiol,2009,30:569-574.
  • 6Ogg RJ,Langston JW,Haacke EM,et al.The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration.Magn Reson Imaging,1999,17:1141 -.
  • 7Haacke EM,Cheng NYC,House MJ,et al.Imaging iron stores in the brain using magnetic resonance imaging.Magn Reson Imaging,2005,23:1-25.
  • 8Schenck JF.Magnetic resonance imaging of brain iron.J Neurol Sci,2003,207:99-102.
  • 9Zhang J,Zhang Y,Wang J,et al.Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging:an in vivo MR study.Brain Res,2010,1330:124-130.
  • 10Wallis LI,Paley MN,Graham JM,etal.MRI assessment of basal ganglia iron deposition in Parkinson's disease.J Magn Reson Imaging,2008,28:1061-1067.

共引文献50

同被引文献79

  • 1陈彪,刘焯霖,王枫.中国帕金森病遗传研究进展[J].中华神经科杂志,2005,38(3):160-164. 被引量:9
  • 2陈生弟.帕金森病治疗指南[J].中华神经科杂志,2006,39(6):409-412. 被引量:104
  • 3Tang B Xiong H Sun P Zhang Y Wang D Hu Z Zhu Z Ma H Pan Q Xia JH Xia K Zhang Z.Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease[J].中国生物学文摘,2006,20(8):16-16. 被引量:30
  • 4李静,唐北沙,郭纪锋,张玉虎,谢志国,严新翔,沈璐,江泓,张学伟,夏昆,潘乾.多巴反应性肌张力障碍GCH1基因突变分析[J].中华医学遗传学杂志,2007,24(3):302-304. 被引量:9
  • 5Sasaki M, Shibata E, Tohyama K, et al. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease [ J]. Neuroreport, 2006, 17 ( 11 ) : 1215- 1218.
  • 6Ohtsuka C, Sasaki M, Konno K, et al. Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging [ J ]. Neurosci Lett, 2013, 541: 93-98. DOI : 10. 1016/j. neulet. 2013. 02. 012.
  • 7Matsuura K, Maeda M, Yata K, et al. Neuromelanin magnetic resonance imaging in Parkinson's disease and multiple system atrophy[J]. Eur Neurol, 2013, 70 (1-2) : 70-77. DOI: 10. 1159/000350291.
  • 8Jost WH. Autonomic dysfunctions in idiopathic Parkinson' s disease[J]. J Neurol, 2003, 250 Suppl 1: 128-30. DOI: 10. 1007/s00415-003 -1105 -z.
  • 9Fearnley JM, Lees AJ. Ageing and Parkinson' s disease: substantia nigra regional selectivity[J]. Brain, 1991, 114 ( Pt 5) : 2283-2301.
  • 10Schwarz ST, Rittman T, Gontu V, et al. Tl-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease [Jl. Mov Disord, 2011, 26(9): 1633-1638. DOI: 10.1002/ mds. 23722.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部